Impact of Ureteral Access Sheath Use on Renal Stone Clearance During Flexible Ureterorenoscopy: A Retrospective Cohort Study Authors: Mohammad Al‐Zubi, Mohammad Ghassab Deameh, Sara Marwan Ghanem, Rania Ahmad Abufarhan, Rhma Ra'afat Alrfooh, Balqees Odeh Alrfooh, Layan Ibrahim Kuran, Hala Ahmad Hazaimeh, Weaam Ali Aladamat, Yaseen Abdelqader Yaseen Asa'd, Mohamad N M Kharashgah, Ghassan Talahmeh Published: 2026 ABSTRACT ABSTRACTBackground and AimsUrinary tract stones (kidney and ureter) are a common medical condition. Recently, advancements in minimally invasive endoscopic procedures have significantly transformed the surgical management of urolithiasis.MethodsThe study enrolled 123 patients with kidney stones who underwent FURS with laser lithotripsy in the period between January 2021 and January 2023. The patients were divided into two groups, first one includes patients who underwent FURS with UAS and the second group include those who underwent FURS without UAS. The patients who underwent FURS with UAS and without UAS were compared based on operative time, complications, and stone‐free rate. The patients underwent CT scan of the urinary tract after two to 4 weeks.ResultsA total of 123 patients who underwent FURS with laser lithotripsy between January 2021 and January 2023 met the inclusion and exclusion criteria. Among them, 58 patients (47%) underwent FURS with UAS, while 65 patients (53%) underwent FURS without UAS. The use of UAS is associated with a significant reduction in operative time and a higher stone‐free rate compared to patients who underwent FURS without UAS. The complications were comparable between patients who underwent FURS with UAS and without UAS.ConclusionThe use of UAS is associated with a significant reduction in operative time and a higher stone‐free rate compared to patients who underwent FURS without UAS.Keywords: flexible ureteroscopy, stone clearance, ureteral access sheath, urolithiasis Abbreviations Computed Tomography French (unit of catheter size) Flexible Ureterorenoscopy Hounsfield Unit Interquartile Range Institutional Review Board Stone‐Free Rate Ureteral Access Sheath Urinary Tract Infection Introduction Urinary tract stones have an estimated incidence of 1 to 13 percent worldwide [1]. The treatment of urinary tract stones has significantly advanced in recent times due to the availability of minimally invasive techniques. The most used technique involves Flexible Ureterorenoscopy (FURS), in which a thin, flexible ureteroscope is passed in a retrograde fashion through the urethra, bladder, and ureter, enabling direct visualization, stone fragmentation, and retrieval [2]. However, the efficiency of FURS is affected by several factors. These include stone characteristics such as stone location, stone size, and stone composition. In addition, patients' anatomical characteristics include patients' renal anatomy and patients' hydronephrosis. Skill level is also an important factor in FURS [3]. Ureteral Access Sheath (UAS) is one of the most commonly employed tools in FURS. UAS varies in size, length, and hydrophilic coating. UAS enables the surgeon to easily advance the ureteroscope. UAS also enables the ureteroscope to pass multiple times. This reduces damage to the ureter. UAS reduces pressure in the renal system as well. In addition, UAS improves irrigation. Therefore, these characteristics make UAS an important tool in FURS [4, 5, 6]. Theoretically, UAS provides access to the collecting system with the ability for multiple entries and exits of the ureter, allowing for evaluating any portion of the kidney, decreasing intrarenal pressure during irrigation, and improving drainage around the scope and visibility, thus protecting the scope when performing lithotripsy and extracting stone fragments. However, recent studies have indicated that UAS usage in FURS reduces the duration of surgery and improves SFR. Nevertheless, there have been concerns regarding UAS use and the risk of ureteral injury, including ureteral strictures due to excessive dilation, damage to the ureteral wall during insertion, and the potential for ureteral ischemia [4, 5, 6]. Due to the controversy surrounding UAS usage in FURS, this study seeks to examine the safety and efficacy of UAS usage in FURS as compared to non‐usage, also aims to contribute to an in‐depth understanding of the benefits and limitations associated with UAS usage in FURS. The findings of this study hope to be useful in enhancing decision‐making in urolithiasis management. Methods Study Design and Setting This study was conducted in accordance with the Declaration of Helsinki for retrospective studies and reported following the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines. The participants were all adults, and their consent to participate in the study has been obtained. In the study, the data was collected on 123 patients with kidney stones, treated with FURS with laser lithotripsy as a primary intervention, between January 2021, and January 2023. Written informed consent to access the data for this study has been obtained from all the patients, and the data were accessed in November 2024. After counselling the patients, the patients were divided into two groups, i.e., the first group of patients were those who were treated with FURS without the use of UAS due to the non‐availability of the suitable size of UAS for the patient, or could not be inserted up to renal pelvis, for example, due to large prostate, then the flexible ureteroscope was inserted under direct vision into the ureter and kidney over a guidewire, while the second group consisted of the patients who were treated with FURS with the use of UAS. Participants The study design involved 123 patients with kidney stones who had FURS as a primary treatment. All the patients had their kidney stones diagnosed before the procedure using urinary tract CT without contrast, which can also be used 2 to 4 weeks post‐surgery to check whether the patient was stone‐free or not. The study was divided into two groups, with the first group undergoing FURS without UAS, and the second group undergoing FURS with UAS. We included patients who had FURS between January 2021 and January 2023, had no prior stenting, no preoperative urinary tract infection, and no congenital anomalies of the kidney, such as a horse shoe kidney. We excluded patients who had no CT scans done post‐surgery to check whether the patient was stone‐free or not. Intervention For both groups, the procedure began with ureteroscopy using a semi‐rigid 7‐French (Fr) ureteroscope. A guidewire was then inserted into the ureter. In the first group the flexible ureteroscope was inserted directly into the ureter and advanced to the kidney without the use of UAS because of either unavailability of suitable UAS size for the patient or inability to insert UAS, while in second group UAS (diameter 10/12, with length 35 cm in female and 45 cm in male) was placed under fluoroscopic guidance, followed by a 9‐French flexible ureteroscope from PUSEN company. Holmium Laser PUSEN used, with fiber size 272 micron in diameter used with all operations done using dusting mode with no need to extract stone fragments. A ureteral stent was placed in all patients postoperatively to reduce pain caused by oedema or the passage of small stone fragments. Operation time was calculated from the time of surgical draping excluding anesthesia time as to eliminate time used on anesthesia induction and focusing on actual operation time. All patients received prophylactic antibiotics before surgery and were discharged on the same day after full recovery. Patients were classified into two groups based on the use of UAS, and both groups were assessed for operative time, complications, and stone‐free rates. A urinary tract CT scan was performed for all patients two to 4 weeks postoperatively to evaluate stone‐free status. Patients were considered stone‐free if residual renal stone fragments were ≤ 3 mm anywhere in the urinary tract. It should be noted that following laser lithotripsy, stone fragments may migrate from their original location (e.g., from the renal collecting system into the ureter); therefore, post‐operative CT assessment evaluated the entire urinary tract for residual fragments and not solely the original stone site [7]. Outcomes and Variables The primary outcome for the study was to assess the effect of the use of UAS in FURS for the surgical treatment of kidney stones on operative time and stone‐free rate. After the operation, the patients were monitored for complications like urinary infections, bleeding, readmission, ureteric injuries, and emergency visits. The stone‐free rate was also determined using a CT scan of the urinary tract taken after two to 4 weeks after surgery. The data were analyzed for both groups in terms of age, gender, operation time, size and density of the stones, stone‐free rate, and complications. Statistical Analysis The statistical analysis was conducted using Jamovi statistical software version 2.6 [8]. Categorical variables were analyzed using the Pearson chi‐square test and presented as frequencies and percentages with numerators and denominators. Continuous variables were tested for normality and, as data were not normally distributed, were presented as median and interquartile range (IQR) and compared between groups using the Wilcoxon rank‐sum test (Mann‐Whitney U test). All statistical tests were two‐sided, and a p value of less than 0.05 was considered statistically significant. Statistical reporting followed the guidelines recommended for clinical research in urology [9]. Results Patient and Stone Characteristics With Surgical Outcomes A total of 123 patients who fulfilled the inclusion and exclusion criteria were included in the study and divided into two groups. The first group consisted of 58 patients (47%), while the second group consisted of 65 patients (53%), with and without the use of UAS, respectively. The median age of all patients included in the study was 37 years. In terms of gender, most of the patients included in the study were male, i.e., 87 (70.7%), while 36 patients were female, i.e., 29.3%. The median operative time for all patients included in the study was 40 min. In terms of postoperative complications, 6 patients (4.9%) experienced complications according to the Clavien‐Dindo classification, of which 4 patients suffered from urinary tract infection (Grade II), 1 patient suffered from ureteric colic (Grade I), and 1 patient suffered from hematuria (Grade I), all of whom were managed conservatively without the need for any surgical intervention. Analysis of stone characteristics revealed that most of the patients included in the study had a stone located in the lower calyx, i.e., 55 patients (44.7%), while in terms of stone size, 102/123 (82.9%) of the patients included in the study had a stone size of 1–2 cm, with a median stone size of 14 mm and a median stone density of 900 Hounsfield units (HU), while most of the patients, i.e., 91/123 (74%), had a single stone, and in case of multiple stones (more than one) then cumulative size and density was considered. In terms of postoperative stone clearance, an overall stone‐free rate of 101/123 (82.1%) was achieved [Table 1]. Table 1Demographic, stone characteristics, and surgical outcomes.VariableOverall (N = 123) Median (IQR), n (%)Age37 (25.5)GenderFemale36 (29.3%)Male87 (70.7%)Operation time40 (15)Complications6 (4.9%)Stone free statusYes101 (82.1%)No22 (17.9%)Stone characteristicsStone sitePelvis42 (34.1%)Upper13 (10.6%)Middle13 (10.6%)Lower55 (44.7%)Stones number191 (74.0%)225 (20.3%)37 (5.7%)Stone size (mm)14 (3.25)< 1 cm10 (8.1%)1–2 cm102 (82.9%)> 2 cm11 (8.9%)Stone density (HU)900 (300) Demographic, stone characteristics, and surgical outcomes. Impact of Access Sheath Usage on Surgical Outcomes On comparing both groups in terms of age and gender, it was found that there were no significant differences, as indicated by p = 0.50 and p = 0.68, respectively. In addition, there were no significant differences noted in terms of stone density, size, and number between the two groups. The results of this study showed that the use of UAS was associated with significantly shorter operative times. The median operative time was found to be significantly shorter in the UAS group, i.e., 30.0 min, compared to the non‐UAS group, i.e., 45.0 min (p < 0.01). In addition, the stone‐free rate was significantly higher in the UAS group, i.e., 58/65 (89%), compared to the non‐UAS group, i.e., 43/58 (74%) (p = 0.03). However, the complication rate did not show any significant differences between the two groups, i.e., 3/58 (5%) of the patients experienced complications in each group (p = 0.89). A comparison of demographics, stone characteristics, and surgical outcomes of the UAS group and non‐UAS group of patients is presented in Table 2. Table 2Comparison of demographics, stone characteristics, and surgical outcomes with and without access sheath use.NoYes N (N = 58)(N = 65)Test statisticAge12327.9 41.0 52.026.0 35.0 50.0 p = 0.50b Gender: Male1230.7 40/580.7 47/65 p = 0.68a Operation time12340.0 45.0 50.830.0 30.0 40.0 p < 0.01b Complications: Yes1230.1 3/580.0 3/65 p = 0.89a Stone‐free status: Yes1230.7 43/580.9 58/65 p = 0.03a Stone size12312.5 14.0 16.012.8 14.0 16.7 p = 0.82b Stone size category123 p = 0.51a < 1 cm0.1 3/580.1 7/651–2 cm0.9 50/580.8 52/65> 2 cm0.1 5/580.1 6/65Stone density123800.0 900.0 1000.0700.0 800.0 1000.0 p = 0.26b Stone numbers123 p = 0.83a 10.7 43/580.7 48/6520.2 11/580.2 14/6530.1 4/580.0 3/65 Note: N is the number of non‐missing values. a: Pearson, b: Wilcoxon. Comparison of demographics, stone characteristics, and surgical outcomes with and without access sheath use. Note: N is the number of non‐missing values. a: Pearson, b: Wilcoxon. Discussion Currently, UAS and FURS is widely accepted by urologists in the management of patients with urolithiasis because of the difficulties that arise when using the older models of ureteroscopes that are stiff and broad in width, as well as having limited deflection angles when introducing them into the ureter [10]. Recent advances in ureteroscopes have made them lighter and more flexible compared to the older models, making them more effective in the management of patients undergoing FURS. These recent advances in ureteroscopes have made them easier to manoeuvre in the urinary system, potentially making it possible to carry out operations without the need for UAS. This has made the use of UAS in FURS operations questionable because of the fear of complications that may arise [11]. In our study, we observed that the use of UAS resulted in a significant reduction in the time of operation. This is in line with the findings of similar authors. For instance, in a study by Pardalidis et al., it was established that UAS enhances the manipulation of the instrument and the fragmentation of the stone, resulting in a reduction in the time of operation [12]. The reduction in time of operation is advantageous because it helps in reducing the cost of the operation, making it easier to promote the use of UAS. However, the largest non‐randomized prospective multicenter study by the Endourological Society's clinical research office involving 2239 patients showed that UAS resulted in an increase in the time of operation by 80 min compared to 64.7 min in the control group that did not undergo UAS [13]. Similar findings were observed in a study by Sari et al., who carried out a retrospective study involving 1808 patients, 1489 of whom underwent FURS with UAS [14]. The large size of the stone in the UAS group in these two studies may have contributed to the prolonged time of operation. A similar study by Cristallo et al. This study also demonstrated that the surgical time for the non‐UAS group was less than for the UAS group, i.e., 65 min and 90 min, respectively. The p‐value for this study was found to be (p = 0.01) [11]. Lima et al. carried out a prospective comparative nonrandomized study for a period of 7 years (2012–2018). A total of 338 patients were included in this study. The results also demonstrated an increase in operation time for the UAS group compared to the non‐UAS group, i.e., 54 ± 25.8 min and 41.3 ± 22.2 min, respectively [15]. On the other hand, no significant difference in operation time was demonstrated in two prospective randomized controlled trials [16, 17]. Regarding SFR, an earlier systematic review and meta‐analysis found no significant differences in SFR, surgical duration, and intraoperative adverse events for UAS. However, UAS was associated with a significantly higher number of postoperative adverse events [18]. In contrast, in a retrospective study carried out by L'Esperance et al., which included 256 cases of ureteroscopy, it was demonstrated that SFR was significantly higher in the UAS group (79%) than in the non‐UAS group (67%), and the P‐value for this study was found to be (p = 0.042) [5]. Conversely, in a prospective comparative nonrandomized study carried out by Lima et al., no significant difference in SFR was demonstrated for the UAS and non‐UAS groups. Even though SFR was found to be less for the UAS group (88%) than for the non‐UAS group (94%), this difference was not statistically significant, and the P‐value for this study was found to be (p = 0.07) [15]. Also, similar study involving 280 patients found that the SFR for the UAS group was 86%, while for the non‐UAS group, the SFR was 87%. One of the major concerns regarding the use of UAS is whether it would increase the risk of complications. In our study, the complications were very few in both groups, i.e., 5% each. However, this was not significant between the groups (p = 0.89) [19]. This is in concurrence with other studies conducted by different authors. A study conducted by Lima et al. showed that complications were not increased in patients who underwent UAS [15]. However, a prospective randomized study conducted by Singh et al. showed that a higher incidence of complications was seen in patients who underwent UAS [16]. However, this was not significant (4.88% vs. 0%, p = 0.157). This shows that complications are not increased in patients who underwent UAS, as supported by our study where very few complications were seen in both groups. However, a prospective multicenter study conducted by Traxer et al. showed that UAS significantly reduced postoperative infectious complications such as fever, UTI, and sepsis. In this study, these complications were seen in 28.6%, 18.6%, and 4.3%, respectively, in patients who underwent UAS. However, in patients who did not undergo UAS, these complications were seen in 39.1%, 23.9%, and 15.2%, respectively [13]. This study has several limitations. First, the postoperative follow‐up period was limited to two to 4 weeks, which is sufficient to assess short‐term complications but inadequate for evaluating long‐term outcomes such as ureteral stricture formation; future studies should incorporate longer follow‐up periods. Second, the sample size was relatively small, which may have limited statistical power. Third, the study did not account for differences among various UAS types or flexible ureteroscope models, which could influence outcomes. Fourth, this study carries an important selection bias: patients in the non‐UAS group were not intentionally managed without a UAS; rather, this group comprised cases in which UAS insertion either failed after a single attempt or an appropriately sized sheath was unavailable. The time spent attempting UAS insertion is therefore included in the operative time of the non‐UAS group, which may have artificially prolonged their recorded operative time. However, because only one insertion attempt was made before abandoning the UAS, the additional time was minimal and unlikely to fully account for the observed difference. Fifth, ureteral narrowing which precluded UAS use in some patients may independently reduce the likelihood of achieving stone‐free status postoperatively, introducing a further source of selection bias between the two groups. Conclusion The findings have shown that although there is a possibility of causing minor injury to the ureters when applying the UAS, it is still much more beneficial compared to the risk. The application of the UAS has been seen to lead to shorter operative time, chances for being stone‐free, and similar complication rates compared to when it is not applied. These findings have shown the benefits of applying the UAS in order to increase the chances for a successful flexible ureteroscopy. Author Contributions Mohammad Al‐Zubi: conceptualization, data curation, methodology, investigation, formal analysis, project administration, resources, supervision, software, validation, visualization, writing – original draft, writing – review and editing. Mohammad Ghassab Deameh: conceptualization, data curation, funding acquisition, investigation, methodology, validation, visualization, project administration, writing – review and editing, writing – original draft. Sara Marwan Ghanem: investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing – review and editing. Rania Ahmad Abufarhan: investigation, methodology. Rhma Ra'afat Alrfooh: investigation, data curation, resources, project administration, writing – review and editing. Balqees Odeh Alrfooh: investigation, data curation, resources, project administration, writing – review and editing. Layan Ibrahim Kuran: investigation, resources, validation, supervision, writing – review and editing. Hala Ahmad Hazaimeh: investigation, resources, validation, supervision, writing – review and editing. Weaam Ali Aladamat: investigation, resources, validation, supervision, writing – review and editing. Yaseen Abdelqader Yaseen Asa'd: investigation, resources, validation, supervision, writing – review and editing. Mohamad N. M. Kharashgah: investigation, software, validation, supervision, writing – review and editing. Ghassan Talahmeh: supervision, validation, writing – review and editing. Funding The research has not received any specific grant from any funding agency in the public, commercial, or non‐profit sectors. The absence of external funding had no role in study design; collection, analysis, or interpretation of data; writing of the report; or the decision to submit the report for publication. Ethics Statement Ethical approval for this research has been obtained from the Research Ethics Committee of the Faculty of Medicine and the Institutional Review Board (IRB) at Yarmouk University (IRB/2024/483). Consent Informed consent for publication of the identifying information/images in this manuscript has been obtained from the relevant parties. Conflicts of Interest The authors declare no conflicts of interest. Transparency Statement The lead author Mohammad Al‐Zubi affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. Acknowledgments The authors have nothing to report. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. The data supporting the findings of this research are available upon request from the corresponding author. The data are not publicly available due to privacy concerns. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. The data supporting the findings of this research are available upon request from the corresponding author. The data are not publicly available due to privacy concerns.